RECRUITING

Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.

Official Title

Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome

Quick Facts

Study Start:2024-06-11

Study Completion:2027-12-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06433115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Age: 18-45 years of age * BMI: 18-35 kg/m2 * Willingness to consume study foods. * Willing to comply with study protocol. * Consistent diet and activity patterns for 4 weeks * Weight stable (≤5 kg change over the last 3 months) * Non-smoker \>1 year or more	* Allergies to foods provided in the study * Diabetes * Gastrointestinal disease and/or bariatric surgery * Uncontrolled hypertension and blood pressure ≥ 180/110 * Illicit drug use * Recent consumption of antibiotics * Recent start of medications that affect metabolism or appetite. * Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia * Pregnant or lactating individuals * Taste or smell disorders

Inclusion Criteria

Exclusion Criteria

* Age: 18-45 years of age
* BMI: 18-35 kg/m2
* Willingness to consume study foods.
* Willing to comply with study protocol.
* Consistent diet and activity patterns for 4 weeks
* Weight stable (≤5 kg change over the last 3 months)
* Non-smoker \>1 year or more

* Allergies to foods provided in the study
* Diabetes
* Gastrointestinal disease and/or bariatric surgery
* Uncontrolled hypertension and blood pressure ≥ 180/110
* Illicit drug use
* Recent consumption of antibiotics
* Recent start of medications that affect metabolism or appetite.
* Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia
* Pregnant or lactating individuals
* Taste or smell disorders

Contacts and Locations

Study Contact

Jaapna Dhillon

CONTACT

573-884-2103

jdhillon@missouri.edu

Principal Investigator

Jaapna Dhillon, PhD

PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Study Locations (Sites)

University of Missouri-Columbia

Columbia, Missouri, 65211

United States

Collaborators and Investigators

Sponsor: University of Missouri-Columbia

Jaapna Dhillon, PhD, PRINCIPAL_INVESTIGATOR, University of Missouri-Columbia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-11

Study Completion Date2027-12-01

Study Record Updates

Study Start Date2024-06-11

Study Completion Date2027-12-01

Terms related to this study

Additional Relevant MeSH Terms

Diet Intervention